Thus, additional studies are required to tease apart the contribution of white Ad-FGF21 to circulating FGF21 levels that are characteristic of obesity, and whether Ad-FGF21 can impact other organs systemically, such as the brain. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.